Skip to main content
GeneBioTechCo.,Ltd. logo

GeneBioTechCo.,Ltd. — Investor Relations & Filings

Ticker · 086060 ISIN · KR7086060001 KO Manufacturing
Filings indexed 120 across all filing types
Latest filing 2026-01-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 086060

About GeneBioTechCo.,Ltd.

http://www.gbtkorea.com

GeneBioTechCo.,Ltd., operating as GBTKOREA, is a specialized manufacturer of core components for medical X-ray imaging systems. Established in 2002, the company focuses on the design and production of high-frequency X-ray generators and related electronic systems. It provides comprehensive Original Equipment Manufacturer (OEM) customization services, developing tailored solutions for clients in the global medical equipment industry.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details the acquisition and disposal of shares by a major shareholder (Kim Sung-ho) and a related entity (Renew Medical Co., Ltd.) in the company 'JinBioTech'. This document type is specifically used to notify the market when a shareholder crosses a significant ownership threshold (typically 5%). Therefore, it falls under the 'Major Shareholding Notification' category.
2026-01-28 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '진바이오텍' covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an individual or entity acquires a significant stake (typically 5% or more) in a company. It details the reporter's identity, the number of shares held, the purpose of the holding (in this case, 'management participation'), and a detailed log of share transactions. This falls under the 'Major Shareholding Notification' category.
2025-08-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by a major shareholder (Kim Sung-ho) in the company JinBioTech. This type of filing is used to notify the market and regulators of significant changes in share ownership levels, which corresponds to the 'Major Shareholding Notification' category.
2025-07-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership. This specific document details the acquisition and disposal of shares by a major shareholder (Kim Sung-ho and related party Renew Medical) in the company JinBioTech. It falls under the category of Major Shareholding Notification (MRQ) as it tracks the percentage of ownership and changes in holdings.
2025-06-27 Korean
[기재정정]신규시설투자등(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Jinbiotech) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment completion date and provides updated investment figures. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment, and it does not fit into the other specific categories like M&A or Share Issues, it is best classified as a general Regulatory Filing (RNS).
2025-06-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.